Morgan Stanley raises Johnson & Johnson price target to $294
Morgan Stanley analyst Terence Flynn maintained an Overweight rating on Johnson & Johnson and raised the price target to $294 from $284.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on Johnson & Johnson and raised the price target to $294 from $284. The revised target suggests increased confidence in the company's valuation potential following the adjustment.
The rating action reflects an updated assessment of the stock's performance outlook. Johnson & Johnson continues to be viewed favorably within the analyst's coverage universe, as evidenced by the retention of the Overweight designation alongside the higher price objective.
What specific factors drove Morgan Stanley to increase the price target for Johnson & Johnson?
How might this rating upgrade influence investor sentiment toward Johnson & Johnson in the short term?
What are the potential risks that could prevent Johnson & Johnson from reaching the new $294 price target?

































